Combination therapy comprising Gemcitabine for the treatment of pancreatic cancer
- Application ID: EP11851046
- Status: █ PATENT GRANTED
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). GlaxoSmithKline and Novartis Pharma AG are specialized in A61. GlaxoSmithKline, Novartis Pharma AG is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.